• Follow us:

VIDEOS/PODCASTS


PODCAST: 09/27/2021

Interview of Microbiome Power with Ross Youngs, CEO of the Biosortia Microbiomics.

Biosortia Microbiomics is developing genuinely disruptive technology for mining of microbiomes. It was our great pleasure to have the opportunity for an interview with Mr. Ross Youngs, Founder and CEO of Biosortia.

PODCAST: 09/09/2021

Owner Interview: Disruptive Innovation Isn’t Just for Big Business with Ross Youngs The Revenue Throughput Podcast || Episode 53

Today’s guest is Ross Youngs, CEO of Univenture and a long time entrepreneur. He has successfully taken businesses from small investments to hundreds of millions of dollars in revenue. Today’s we will be talking about disruptive innovation and how it’s not a game that is only for the biggest companies like Microsoft or Apple but is actually something you can follow with a couple key steps.

Ross has spent over 30 years inventing products, technologies and processes for a variety of industries, and holds over 75 patents worldwide. He is driven to innovate by a focus on what is better, faster and less expensive.

Ross’ recent major innovations include an R&D 100 Award for collaboration on biopolymer technologies. In 2009, Biosortia was awarded a $6 million ARPA-E grant for its algal harvesting technology, which helped lead to the development of Biosortia’s drug discovery platform.

After listening to today’s episode, check out https://www.biosortia.com/ to learn more about Ross Youngs and Biosortia.

VIDEO: 02/26/2021

Rock Stars of R&D, Episode 29, Ross Youngs

An Engineering Entrepreneur in Technology and now as CEO of Biosortia, Microbiomes and Microbiomics, Ross spent a career driving breakthrough technologies to fruition and acceptance.

VIDEO: 02/10/2021

Ross Youngs’ presentation during the “Innovation Spotlight”

Segment of the meeting of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB)

VIDEO: 09/25/2020

Jesse McLaughlin & Ross Youngs.

In the world of drug discovery, for the most part, it hasn’t changed much in decades. Ross Youngs, CEO of Biosortia Pharmaceuticals is looking to change that with a better understanding of the microbiome.

PODCAST: 09/24/2020

Through an interesting turn of events, Biosortia discovered they had access to large amounts of Aquatic Microbiome. With a broad range of capabilities, they are able to extrapolate this into drug discovery. Ross believes that Biosortia’s ability to mine microbiome on such a large scale will change drug discovery in the coming years.

PODCAST: 08/05/2020

Delighted to share Episode 1, Season 1 of The Sophia Consulting Firm’s “Amplifying Scientific Innovation #Podcast” with Ross Youngs, Founder, and CEO, Biosortia Pharmaceuticals.

PODCAST: 04/02/2020

Ross Youngs has spent over 30 years inventing products, technologies, and processes for a variety of industries, and holds over 75 patents worldwide. He is driven to innovate by a focus on what is better, faster, and less expensive. Ross’ recent major innovations include an R&D 100 Award for collaboration on biopolymer technologies. In 2009, Biosortia was awarded a $6 million ARPA-E (U.S. Dept. of Energy R&D) grant for its algal harvesting technology, which helped lead to the development of Biosortia’s drug discovery platform.

VIDEO: 09/16/2019

Biosortia Pharmaceutical Presentation.

Enabling new, faster and less expensive drug discovery through unprecedented access to microbiome chemistry.

VIDEO: 07/12/2019

The Donna Drake Show Live It Up with Ross O Youngs on Biosortia Pharmaceutical.

Extract Value from Natural and Chemically Modified Compounds.

Pre-clinical portfolio of microbiome-derived immune-modulating peptides and other small molecules with exclusive technologies and the scientific expertise for discovering, expanding, and advancing a valuable IO/I pipeline.



Pin It on Pinterest